These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
722 related items for PubMed ID: 8051487
1. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes. Ofosu-Appiah W, Mokhtarian F, Shirazian D, Grob D. J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487 [Abstract] [Full Text] [Related]
2. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis. Shinomiya N, Yata J. Clin Exp Immunol; 1981 Nov; 46(2):277-85. PubMed ID: 6978218 [Abstract] [Full Text] [Related]
3. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Atassi MZ, Oshima M, Deitiker P. Crit Rev Immunol; 2001 Nov; 21(1-3):1-27. PubMed ID: 11642597 [Abstract] [Full Text] [Related]
4. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis. Zhang J, Zhou WB, Wang HL, Guo SS. Hum Antibodies; 1997 Nov; 8(2):90-4. PubMed ID: 9289393 [Abstract] [Full Text] [Related]
5. T cell responses to human recombinant acetylcholine receptor-alpha subunit in myasthenia gravis and controls. Sun JB, Harcourt G, Wang ZY, Hawke S, Olsson T, Fredrikson S, Link H. Eur J Immunol; 1992 Jun; 22(6):1553-9. PubMed ID: 1376263 [Abstract] [Full Text] [Related]
6. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis. Hohlfeld R, Conti-Tronconi B, Kalies I, Bertrams J, Toyka KV. J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794 [Abstract] [Full Text] [Related]
7. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis. Fujii Y, Hashimoto J, Monden Y, Ito T, Nakahara K, Kawashima Y. J Immunol; 1986 Feb 01; 136(3):887-91. PubMed ID: 2416838 [Abstract] [Full Text] [Related]
8. Transforming growth factor-beta directs IgA switching in human B cells. van Vlasselaer P, Punnonen J, de Vries JE. J Immunol; 1992 Apr 01; 148(7):2062-7. PubMed ID: 1347548 [Abstract] [Full Text] [Related]
9. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis. Fujii Y, Lindstrom J. J Immunol; 1988 Nov 15; 141(10):3361-9. PubMed ID: 2972772 [Abstract] [Full Text] [Related]
10. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides. Atassi MZ, Oshima M. Crit Rev Immunol; 1997 Nov 15; 17(5-6):481-95. PubMed ID: 9419435 [Abstract] [Full Text] [Related]
11. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides. Fujii Y, Lindstrom J. J Immunol; 1988 Mar 15; 140(6):1830-7. PubMed ID: 2450133 [Abstract] [Full Text] [Related]
12. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients. Saito R, Onodera H, Tago H, Suzuki Y, Shimizu M, Matsumura Y, Kondo T, Itoyama Y. J Neuroimmunol; 2005 Dec 30; 170(1-2):172-8. PubMed ID: 16214223 [Abstract] [Full Text] [Related]
13. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis. Willcox HN, Newsom-Davis J, Calder LR. Clin Exp Immunol; 1984 Oct 30; 58(1):97-106. PubMed ID: 6236921 [Abstract] [Full Text] [Related]
14. The in vitro effects of D-penicillamine upon anti-AChR production by thymic and peripheral blood lymphocytes from patients with myasthenia gravis. Scadding GK, Calder L, Newsom-Davis J. Muscle Nerve; 1983 Oct 30; 6(9):656-60. PubMed ID: 6606776 [Abstract] [Full Text] [Related]
15. Superantigen-mediated human monocyte-T lymphocyte interactions are associated with an MHC class II-, TCR/CD3-, and CD4-dependent mobilization of calcium in monocytes. Damaj B, Mourad W, Naccache PH. J Immunol; 1992 Sep 01; 149(5):1497-503. PubMed ID: 1380531 [Abstract] [Full Text] [Related]
16. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor. Zhang YP, Tzartos SJ, Wekerle H. Eur J Immunol; 1988 Feb 01; 18(2):211-8. PubMed ID: 2450756 [Abstract] [Full Text] [Related]
17. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis. Yoshikawa H, Lambert EH, Walser-Kuntz DR, Yasukawa Y, McCormick DJ, Lennon VA. J Immunol; 1997 Aug 01; 159(3):1570-7. PubMed ID: 9233656 [Abstract] [Full Text] [Related]
18. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes. Nagvekar N, Moody AM, Moss P, Roxanis I, Curnow J, Beeson D, Pantic N, Newsom-Davis J, Vincent A, Willcox N. J Clin Invest; 1998 May 15; 101(10):2268-77. PubMed ID: 9593783 [Abstract] [Full Text] [Related]
19. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains. Wu B, Shenoy M, Goluszko E, Kaul R, Christadoss P. J Immunol; 1995 Apr 01; 154(7):3603-10. PubMed ID: 7897239 [Abstract] [Full Text] [Related]
20. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor. Bellone M, Ostlie N, Lei SJ, Wu XD, Conti-Tronconi BM. J Immunol; 1991 Sep 01; 147(5):1484-91. PubMed ID: 1715360 [Abstract] [Full Text] [Related] Page: [Next] [New Search]